NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 28 filers reported holding NIVALIS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,374,000 | +17.1% | 2,644,806 | +41.9% | 0.99% | +6.9% |
| Q1 2017 | $5,444,000 | +30.4% | 1,864,474 | 0.0% | 0.93% | +10.4% |
| Q4 2016 | $4,176,000 | -70.0% | 1,864,474 | +9.1% | 0.84% | -68.0% |
| Q3 2016 | $13,900,000 | +56.8% | 1,709,673 | -11.3% | 2.62% | +38.7% |
| Q2 2016 | $8,862,000 | +37.4% | 1,926,443 | +24.5% | 1.89% | +18.3% |
| Q1 2016 | $6,450,000 | -30.3% | 1,546,743 | +29.4% | 1.60% | +1.3% |
| Q4 2015 | $9,249,000 | – | 1,195,013 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|